Cargando…

Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial

BACKGROUND: Antipsychotic treatment may improve clinical insight. However, previous studies have reported inconclusive findings on whether antipsychotics improve insight over and above the reduction in symptoms of psychosis. These studies assessed homogeneous samples in terms of stage of illness. Ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stabell, L.A, Johnsen, E., Kroken, R. A, Løberg, E.M., Blindheim, A., Joa, I., Reitan, S.K., Rettenbacher, M., Munk-Jørgensen, P., Gjestad, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311854/ https://www.ncbi.nlm.nih.gov/pubmed/37386462 http://dx.doi.org/10.1186/s12888-023-04981-9

Ejemplares similares

Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro)
por: Kjelby, Eirik, et al.
Publicado: (2023)

T206. ANTIPSYCHOTIC EFFECTIVENESS FOCUSING ON INSIGHT
por: Stabell, Lena, et al.
Publicado: (2020)

Does childhood trauma influence cognitive functioning in schizophrenia? The association of childhood trauma and cognition in schizophrenia spectrum disorders.
por: Mørkved, N., et al.
Publicado: (2020)

S57. TREATMENT SATISFACTION IN ACUTE PHASE PSYCHOSIS: COMPARISON BETWEEN ANTIPSYCHOTIC NAïVE AND PREVIOUSLY MEDICATED PATIENTS
por: Stabell, Lena, et al.
Publicado: (2018)

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
por: Kjelby, Eirik, et al.
Publicado: (2011)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT
por: Anda, Liss, et al.
Publicado: (2021)

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
por: Johnsen, Erik, et al.
Publicado: (2013)

Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms
por: Anda, Liss, et al.
Publicado: (2019)

Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia
por: Liu, Jin-Ling, et al.
Publicado: (2023)

Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study
por: Hoekstra, Sanne, et al.
Publicado: (2021)

Differential Effectiveness of Atypical Antipsychotics on Hallucinations: A Pragmatic Randomized Controlled Trial
por: Sinkeviciute, Igne, et al.
Publicado: (2021)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Aripiprazole for olanzapine-induced symptomatic hyper prolactinemia
por: Aggarwal, Ashish, et al.
Publicado: (2010)

S87. THE INITIAL CHANGE IN THE SERUM LEVEL OF C-REACTIVE PROTEIN IN ACUTE PSYCHOSIS IS ASSOCIATED WITH COGNITIVE PERFORMANCE IN LATER PHASES
por: Fathian, Farivar, et al.
Publicado: (2018)

The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis
por: Johnsen, Erik, et al.
Publicado: (2016)

Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis
por: Fathian, Farivar, et al.
Publicado: (2018)

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010)

S3. CHILDHOOD TRAUMA AND COGNITIVE FUNCTIONING IN SCHIZOPHRENIA SPECTRUM DISORDERS: EFFECT OF FREQUENCY AND TYPE OF CHILDHOOD TRAUMA
por: Morkved, Nina, et al.
Publicado: (2018)

Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
por: Nielsen, Mette Ødegaard, et al.
Publicado: (2022)

Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness
por: Drosos, Petros, et al.
Publicado: (2022)

The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study
por: Larsen, Jeanette Brun, et al.
Publicado: (2021)

Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
por: Kumar, Subodh, et al.
Publicado: (2014)

Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report
por: Yang, Hae-Jung, et al.
Publicado: (2022)

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study
por: Liang, Ying, et al.
Publicado: (2017)

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
por: Woo, Young Sup, et al.
Publicado: (2022)

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
por: Bahk, W.-M., et al.
Publicado: (2023)

T16. SCHIZOPHRENIA SPECTRUM DISORDER: DEPRESSION TRAJECTORIES AND IMMUNE MARKERS
por: Hoprekstad, Gunnhild, et al.
Publicado: (2020)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2020)

An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2012)

Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross-Sectional Study
por: Johnsen, Erik, et al.
Publicado: (2011)

Corrigendum: An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2013)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

Amisulpride induced mania
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
por: Soria-Chacartegui, Paula, et al.
Publicado: (2021)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009)

The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement
por: Anda, Liss, et al.
Publicado: (2016)

QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics
por: Johnsen, Erik, et al.
Publicado: (2013)

Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis
por: Men, Peng, et al.
Publicado: (2018)

Patients with Schizophrenia Fail to Up-Regulate Task-Positive and Down-Regulate Task-Negative Brain Networks: An fMRI Study Using an ICA Analysis Approach
por: Nygård, Merethe, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pa284uqfs8f5u248m6pkear444